Reimagine Care, the nation’s leading provider of virtual-first
cancer care, proudly announces the expansion of its esteemed
Clinical Advisory Board with the appointment of renowned healthcare
professionals with expertise in care across the cancer continuum.
Comprised of distinguished leaders, the board is poised to provide
strategic guidance and insight to further enhance Reimagine Care's
innovative solutions.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240430740623/en/
Reimagine Care, the nation’s leading
provider of virtual-first cancer care, proudly announces the
expansion of its esteemed Clinical Advisory Board with the
appointment of renowned healthcare professionals with expertise in
care across the cancer continuum. (Graphic: Business Wire)
Led by Medical Director, Dr. Pallav Mehta, the Clinical Advisory
Board brings together a diverse group of experts with extensive
experience across multiple oncology disciplines, including nursing,
specialty medicine, policy, and health technology. Their collective
expertise will play a pivotal role in steering Reimagine Care
towards even greater success in its mission to transform healthcare
delivery and improve patient outcomes.
"We are delighted to welcome such a talented and acclaimed group
of professionals to our Clinical Advisory Board," said Dan Nardi,
CEO of Reimagine Care. "Their depth of knowledge and breadth of
experience will be invaluable as we continue to develop solutions
to address the evolving needs of patients with cancer and their
providers."
Dr. Pallav Mehta, Medical Director for Reimagine Care shares,
“Each member of the Clinical Advisory Board brings a unique
perspective and set of skills that will enrich Reimagine Care's
strategic decision-making process and ensure the company remains at
the forefront of virtual-first cancer care.”
The Clinical Advisory Board will include:
Yousuf Zafar, MD, MHS - Dr. Yousuf
Zafar is a practicing oncologist with more than 20 years of
clinical, research, and healthcare administration experience. He is
driven to optimize patient outcomes while lowering healthcare
costs. Dr. Zafar has most recently served in leadership roles in
the healthcare technology industry. Prior to that, he was a
professor of medicine and chief quality and innovation officer at
the Duke Cancer Institute. He has over 120 peer-reviewed
publications. Dr. Zafar completed his internal medicine residency
at the University of Cincinnati Medical Center and his medical
oncology fellowship at the Duke University Medical Center. He
earned a master’s degree in clinical research at Duke. He is a
Fellow of the American Society of Clinical Oncology and an adjunct
professor at the Duke University School of Medicine.
Robert Hauser, PharmD, PhD - Dr.
Robert Hauser is the Co-Founder and Chief Business Development
& Analytics Officer for Vidence. His responsibilities include
identifying business opportunities to leverage a growing volume of
deep longitudinal clinical-genomic data for use in multiple
healthcare channels including biopharmaceutical, provider and payer
markets. His prior role was Vice President of Clinical Analytics
and HEOR at Cancer Treatment Centers of America. Prior to joining
CTCA, Rob was the Senior Director of External Relations and
Business Development for CancerLinQ at the American Society of
Clinical Oncology.
Dr. Hauser has more than 25 years of
progressively responsible experience in health economic and
strategy planning services related to clinical trial development,
oncology registries, EMR systems, informatics, and business
development. Prior to joining ASCO, he was the Director of
Operations and Informatics at the International Oncology Network
(ION), and was responsible for developing strategy for the use of
informatics data, providing analytics for Oncology Managed Care
Initiatives, developing proposals, budgets, and the execution of
projects from inception to completion.
Dr. Hauser has led more than 25 research
activities, has over 10 peer reviewed publications, served as guest
editor and has presented hundreds of times to audiences large and
small. He currently serves on the Board of Directors for the
Geriatric Oncology Consortium, the Board of Directors for Share for
Cures and serves on the Advisory Board of Doctors Helping Doctors
Transform Healthcare. In the past he has helped shape oncology EHR
use through his appointment on the CCHIT Oncology Work Group in
2010-11.
Shelley Fuld Nasso, MPP – As Chief
Executive Officer, Shelley Fuld Nasso leads the public policy
activities of National Coalition for Cancer Survivorship (NCCS) at
a time of rapid and fundamental health care system change. Shelley
joined NCCS in December 2012 and was named CEO in October 2013.
Prior to joining NCCS, Ms. Nasso served in
leadership roles at Susan G. Komen, where she leveraged Komen’s
grassroots network in Washington, D.C., and in state capitals.
There she built relationships with policymakers and partner
organizations and led a team of staff and volunteer leaders to
influence state budgets and legislation. Ms. Nasso witnessed
first-hand the strengths and flaws of the cancer care system and
embraces the notion that policy change can make cancer care better
for patients and caregivers.
“I am honored to join Reimagine Care’s Clinical Advisory Board.
I look forward to bringing the perspectives of patients to this
effort to revolutionize patient care through technology," said
Shelley Fuld Nasso, MPP. She continues, “I am pleased to be part of
a collaboration aimed at advancing meaningful improvements in
cancer care delivery.”
The expansion of the Clinical Advisory Board marks a significant
milestone for Reimagine Care as it continues to expand its reach
and influence in the healthcare industry. With the guidance and
expertise of these admired healthcare leaders, Reimagine Care is
poised to make even greater strides in its pursuit of transforming
the future of healthcare.
For more information about Reimagine Care, please visit
www.reimaginecare.com.
About Reimagine Care:
We believe people living with cancer deserve a better patient
experience; to feel their best and to spend as much time as
possible with the people they love, doing the things that bring
them joy. Reimagine Care integrates clinical oncology experts and
robust, enabling technologies to deliver a high-touch,
individualized cancer treatment and recovery experience. This
holistic approach relies on the combination of empathy and
knowledge of our clinical care team with our thoughtfully designed
and easy-to-use platform.
Our vision and our approach fuel the delivery of high-quality,
safe, home-centered, coordinated cancer care that makes care more
patient-centric, accessible, affordable, and the first choice for
patients everywhere.
Extending Care Beyond the Clinic.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240430740623/en/
For media inquiries, please contact Nora Anderson at
media@reimaginecare.com.